奥西默替尼
培美曲塞
医学
肿瘤科
内科学
化疗
顺铂
表皮生长因子受体
癌症
埃罗替尼
作者
Stephanie P.L. Saw,Yi Fen Low,Gillianne Lai,Landon L. Chan,Wesley K.Y. Wong,G. Tsui,Olivia H. Chen,A. Seet,Wei Chong Tan,Aaron C. Tan,Johan Chan,Yi Lin Teh,Wan-Ling Tan,Quan Sing Ng,Mei‐Kim Ang,Ravindran Kanesvaran,Wan‐Teck Lim,Daniel S.W. Tan,Tony Mok,Molly Li
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2024-06-15
卷期号:193: 107856-107856
被引量:6
标识
DOI:10.1016/j.lungcan.2024.107856
摘要
Our real-world data supports the efficacy of Pem-Plat-Osi after progression on first-line osimertinib, including L858R and baseline CNS metastases. Chemotherapy initiation within 20d of Osi progression was predictive of superior TTF2.
科研通智能强力驱动
Strongly Powered by AbleSci AI